Medipharm Labs Corp (OTCMKTS: MEDIF) applauds Health Canada for giving the nod to McMaster University to continue researching with MediPharm Labs CBD50 and CBD10:2. The body gave the company’s research partner a no objection letter, giving it the right to engage in its phase 2 trial.
Seeking a working solution for Insomnia.
MediPharm Labs considers the latest development to be a step towards the right direction in treating Insomnia. The company hopes the study will showcase the safety and efficacy of cannabis oil in helping patients struggling with the condition for many years. A Professor at McMaster University called Dr. Benicio Frey would offer leadership to the clinical research group that will conduct the study.
Analysts applaud North America for its significant role in eliminating and diagnosing the stigma surrounding mental health. In addition, the study marks a new dawn as more patients move out in search of working treatment options.
The Researchers seem optimistic about how cannabidiol (“CBD”) with or without THC could bring about a new and exciting dynamic in treatment. For example, it could help in offering a working solution for handling sleep disorders linked to depression.
Strachan speaks out
The researchers will resort to top-quality formulation in conducting the clinical trial. MediPharm Labs vows to stay at the top of its game. It has its Drug Establishment Licence and Cannabis Drug Licence ready, outlining that the licenses will simplify matters. It targets the delivery of clinical trial material that matches Good Manufacturing Practices and pharmaceutical quality standards.
The Interim CEO of MediPharm Labs, Keith Strachan, opines, “As a pharmaceutical company specialized in cannabis, MediPharm Labs is encouraged by the ongoing research and development of drugs containing cannabis. This study will create opportunities to show efficacy in our already commercialized cannabis oil while also making progress on our long-term goal to manufacture pharmaceutical drugs containing cannabinoids as an active ingredient.”
Curaleaf Holdings Inc (OTCMKTS: CURLF) Is Opening a Dispensary at State College
Post Views: 160 Curaleaf Holdings Inc (OTCMKTS: CURLF) is opening a State College Dispensary at 1248 A Atherton St, State...
Puration Inc (OTCMKTS: PURA) Is About to Make Its First Collaboration in the Asia Pacific
Post Views: 406 Puration Inc (OTCMKTS: PURA) is about to strike a deal for its first collaboration in the Asia...
Harborside Inc (OTCMKTS: HBORF) Will Convert Multiple Voting Shares Into Subordinate Voting Shares
Post Views: 2,793 Harborside Inc (OTCMKTS: HBORF) has announced that it will convert its outstanding and issued multiple voting shares...
Trulieve Cannabis Corp (OTCMKTS: TCNNF) Announces Partnership With Khalifa Kush
Post Views: 393 Trulieve Cannabis Corp (OTCMKTS: TCNNF) Khalifa Kush has announced an exclusive partnership. Khalifa Kush is a brand...
Indiva Ltd (OTCMKTS: NDVAF) Launches Jewel Cannabis Tarts
Post Views: 282 Indiva Ltd (OTCMKTS: NDVAF) recently launched Jewel Cannabis Tarts, its latest products into the cannabis Industry. The...
Neptune Wellness Solutions Inc’s (NASDAQ: NEPT) Subsidiary, Sprout Organics, Executes a Partnership With Cocomelon for the Distribution of Organic Produce
Post Views: 297 Sprout Organics, a subsidiary of Neptune Wellness Solutions Inc (NASDAQ; NEPT), recently announced the execution of its...